Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
152 | 4062 | 44.7 | 76% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
121 | 23330 | IRRITABLE BOWEL SYNDROME//NEUROGASTROENTEROLOGY AND MOTILITY//FUNCTIONAL DYSPEPSIA |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | IRRITABLE BOWEL SYNDROME | Author keyword | 1134 | 54% | 36% | 1446 |
2 | IBS | Author keyword | 56 | 37% | 3% | 122 |
3 | FUNCTIONAL GASTROINTESTINAL DISORDERS | Author keyword | 49 | 38% | 3% | 103 |
4 | IRRITABLE BOWEL SYNDROME IBS | Author keyword | 47 | 56% | 1% | 58 |
5 | FUNCT GI MOTIL DISORDERS | Address | 45 | 58% | 1% | 53 |
6 | FUNCTIONAL BOWEL DISORDERS | Author keyword | 39 | 50% | 1% | 56 |
7 | ROME CRITERIA | Author keyword | 38 | 66% | 1% | 35 |
8 | VISCERAL HYPERSENSITIVITY | Author keyword | 34 | 35% | 2% | 80 |
9 | FUNCTIONAL BOWEL DISORDER | Author keyword | 29 | 66% | 1% | 27 |
10 | ALOSETRON | Author keyword | 26 | 61% | 1% | 28 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | IRRITABLE BOWEL SYNDROME | 1134 | 54% | 36% | 1446 | Search IRRITABLE+BOWEL+SYNDROME | Search IRRITABLE+BOWEL+SYNDROME |
2 | IBS | 56 | 37% | 3% | 122 | Search IBS | Search IBS |
3 | FUNCTIONAL GASTROINTESTINAL DISORDERS | 49 | 38% | 3% | 103 | Search FUNCTIONAL+GASTROINTESTINAL+DISORDERS | Search FUNCTIONAL+GASTROINTESTINAL+DISORDERS |
4 | IRRITABLE BOWEL SYNDROME IBS | 47 | 56% | 1% | 58 | Search IRRITABLE+BOWEL+SYNDROME+IBS | Search IRRITABLE+BOWEL+SYNDROME+IBS |
5 | FUNCTIONAL BOWEL DISORDERS | 39 | 50% | 1% | 56 | Search FUNCTIONAL+BOWEL+DISORDERS | Search FUNCTIONAL+BOWEL+DISORDERS |
6 | ROME CRITERIA | 38 | 66% | 1% | 35 | Search ROME+CRITERIA | Search ROME+CRITERIA |
7 | VISCERAL HYPERSENSITIVITY | 34 | 35% | 2% | 80 | Search VISCERAL+HYPERSENSITIVITY | Search VISCERAL+HYPERSENSITIVITY |
8 | FUNCTIONAL BOWEL DISORDER | 29 | 66% | 1% | 27 | Search FUNCTIONAL+BOWEL+DISORDER | Search FUNCTIONAL+BOWEL+DISORDER |
9 | ALOSETRON | 26 | 61% | 1% | 28 | Search ALOSETRON | Search ALOSETRON |
10 | POST INFECTIOUS IRRITABLE BOWEL SYNDROME | 23 | 79% | 0% | 15 | Search POST+INFECTIOUS+IRRITABLE+BOWEL+SYNDROME | Search POST+INFECTIOUS+IRRITABLE+BOWEL+SYNDROME |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | FUNCTIONAL GASTROINTESTINAL DISORDERS | 512 | 53% | 17% | 672 |
2 | IBS | 179 | 68% | 4% | 158 |
3 | DIARRHEA PREDOMINANT | 152 | 86% | 2% | 78 |
4 | SYNDROME IBS | 151 | 86% | 2% | 76 |
5 | IRRITABLE BOWEL SYNDROME | 149 | 14% | 23% | 949 |
6 | IBS PATIENTS | 120 | 74% | 2% | 89 |
7 | MANNING CRITERIA | 102 | 88% | 1% | 49 |
8 | ROME II CRITERIA | 93 | 64% | 2% | 91 |
9 | ALOSETRON | 90 | 60% | 2% | 99 |
10 | COLON SYNDROME | 85 | 79% | 1% | 54 |
Journals |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | NEUROGASTROENTEROLOGY AND MOTILITY | 26 | 11% | 6% | 232 |
2 | JOURNAL OF NEUROGASTROENTEROLOGY AND MOTILITY | 6 | 15% | 1% | 38 |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Irritable Bowel Syndrome A Clinical Review | 2015 | 7 | 86 | 67% |
Global Prevalence of and Risk Factors for Irritable Bowel Syndrome: A Meta-analysis | 2012 | 143 | 94 | 86% |
The efficacy of probiotics in the treatment of irritable bowel syndrome: a systematic review | 2010 | 201 | 32 | 81% |
Crosstalk at the mucosal border: importance of the gut microenvironment in IBS | 2015 | 5 | 191 | 64% |
Effect of Antidepressants and Psychological Therapies, Including Hypnotherapy, in Irritable Bowel Syndrome: Systematic Review and Meta-Analysis | 2014 | 24 | 64 | 89% |
AGA technical review on irritable bowel syndrome | 2002 | 664 | 216 | 77% |
Pathogenesis of IBs: role of inflammation, immunity and neuroimmune interactions | 2010 | 155 | 103 | 83% |
An Evidence-Based Position Statement on the Management of Irritable Bowel Syndrome | 2009 | 217 | 216 | 77% |
Guidelines on the irritable bowel syndrome: mechanisms and practical management | 2007 | 274 | 382 | 76% |
Postinfectious Irritable Bowel Syndrome | 2009 | 236 | 93 | 57% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | FUNCT GI MOTIL DISORDERS | 45 | 58% | 1.3% | 53 |
2 | FUNCT MOTOR DIGEST DISORDERS | 25 | 77% | 0.4% | 17 |
3 | NEUROVISCERAL SCI WOMENS HLTH | 15 | 35% | 0.9% | 35 |
4 | OFF NURSING | 14 | 45% | 0.6% | 23 |
5 | DIGEST SYST UNIT | 12 | 21% | 1.3% | 51 |
6 | GASTROENTEROL CLIN DEV | 12 | 86% | 0.1% | 6 |
7 | UCLA CURE NEUROENTER DIS PROGRAM | 12 | 86% | 0.1% | 6 |
8 | UNC FUNCT GI MOTIL DISORDERS | 12 | 54% | 0.4% | 15 |
9 | NEUROGASTROENTEROL NUTR GRP | 9 | 83% | 0.1% | 5 |
10 | FUNCT GASTROINTESTINAL DISORDERS | 8 | 70% | 0.2% | 7 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000118289 | FUNCTIONAL DYSPEPSIA//DYSPEPSIA//GASTRIC ACCOMMODATION |
2 | 0.0000116506 | SIMETHICONE//1 IODO NONANE//H 2 EXCRETION |
3 | 0.0000112597 | VISCERAL PAIN//COLORECTAL DISTENSION//VISCERAL HYPERALGESIA |
4 | 0.0000097207 | FUNCTIONAL BOWEL DISEASE//CA2 ACTIVATED K K CA CHANNEL//ENTERIC DYSMOTILITY |
5 | 0.0000089894 | RECURRENT ABDOMINAL PAIN//FUNCTIONAL ABDOMINAL PAIN//CHRONIC AND RECURRENT PAIN |
6 | 0.0000088500 | PACESETTER POTENTIALS//SURG EXPT//COLONIC MOTILITY |
7 | 0.0000084824 | CONSTIPATION//SLOW TRANSIT CONSTIPATION//ENCOPRESIS |
8 | 0.0000083636 | OTILONIUM//OTILONIUM BROMIDE//INTERPROTON DISTANCE |
9 | 0.0000075346 | TRIMEBUTINE//TRIMEBUTINE MALEATE//CAS 39133 31 8 |
10 | 0.0000066701 | BILE ACID MALABSORPTION//SEHCAT//75SEHCAT |